This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
Company | Broker Update |
Aviva | Nomura ups TP to 474p from 414p; Buy |
BBA Aviation | Jefferies ups TP to 345p from 290p; Buy |
Catlin | Westhouse cuts TP to 575p from 590p; Add |
Ferrexpo | Morgan Stanley cuts TP to 220p from 320p; Equalweight |
Fresnillo | UBS initiates coverage with a Buy; 1250p TP |
GlaxoSmithKline | Day to Day cuts TP to 1781p from 1990p; Buy |
Glencore Xstrata | Exane BNP Paribas cuts TP 22% to 315p; Neutral |
Grainger | JP Morgan Cazenove upgrades to Neutral from underweight; ups TP to 205p from 170p |
Hochschild Mining | UBS initiates coverage with a Neutral; 210p TP |
International Personal Finance | Citigroup downgrades to Neutral from Buy; ups TP to 700p from 540p |
John Wood Group | Investec ups TP to 900p from 800p; Hold |
Legal & General | Citigroup adds to Preferred lits; Neutral ups TP to 210p from 181p |
Old Mutal | Nomura downgrades to Neutral from Buy; TP 202p |
Petra Diamonds | Citigroup ups TP to 164p from 152p; Buy |
Petra Diamonds | Numis cuts TP to 160p from 170p; Buy |
Prudential | S&P Capital IQ ups TP to 1320p from 1280p; Buy |
Rio Tinto | SocGen ups TP to 3698p from 3571p; Buy |
Royal Bank of Scotland | Goldman Sachs ups TP to 400p from 370p; Buy/Neutral |
Smith & Nephew | Investec cuts TP to 783p from 802p; Hold |
Smith & Nephew | Citigroup downgrades to Neutral from Buy; ups TP to 700p from 540p |
Spirax Sarco Engineering | Investec ups TP to 3050p from 2800p; Hold |
Thomas Cook | Panmure Gordon ups TP to 180p from 164p; Buy |
Whitbread | Panmure Gordon downgrades to Sell from Hold; cuts TP to 2644p from 2688p |
Source: Reuters News, AlphaTerminal, Dow Jones Newswires |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research